US Senate committee takes up bill targeting China's BGI, WuXi Apptec
Send a link to a friend
[March 06, 2024] By
Karen Freifeld
(Reuters) - A bill in the U.S. Senate that would restrict business with
China's BGI, WuXi Apptec and other biotech companies on national
security grounds faces its first big test in Congress on Wednesday.
The draft legislation, which is designed to keep Americans' personal
health and genetic information from foreign adversaries, will be
discussed in a committee meeting and could be changed and either moved
forward for a vote or held back for more discussion.
The bill has spurred deep concern among investors, driving a sell-off in
the shares of WuXi AppTec when news of its introduction first reached
Chinese markets last month.
As currently written, it would prohibit federal agencies from
contracting with China's BGI, MGI, Complete Genomics, WuXi AppTec, their
affiliates and other biotechnology companies deemed of concern. It would
also stop the government from entering into contracts with companies
that use their equipment or services.
But when members of the Homeland Security and Governmental Affairs
Committee meet on Wednesday to markup the bill, it is possible one or
more company names could be stripped from the text.
The companies have denied they pose any security threats.
The committee expects the bill to move forward on a bipartisan basis, an
aide for Senator Gary Peters, chair of the Homeland Security and
Governmental Affairs Committee said.
A companion bill introduced in the House in January accuses BGI, a
genomics company, of posing a threat to U.S. national security through
its collection of genetic data. It describes MGI and Complete Genomics
as subsidiaries and affiliates.
[to top of second column] |
The logo of Chinese drug research and development group WuXi AppTec
is displayed alongside its company website, in this illustration
picture taken February 5, 2024. REUTERS/Florence
Lo/Illustration/File Photo
WuXi Apptec, which provides R&D and manufacturing services to the
pharmaceutical and healthcare industry, allegedly has ties to the
Chinese military, according to the House version of the bill.
The companies have said the proposed legislation contains false,
misleading and unfounded allegations.
Rick Connell, WuXi Apptec's chief operating officer for the U.S. and
Europe, said the company was closely monitoring the markup.
"We are confident that upon considering the facts, lawmakers will
understand that WuXi AppTec does not pose a national security risk,"
Connell said, and is "a trusted partner to customers in the U.S. and
around the world."
BGI Group said it supports the bill's premise of protecting
Americans' personal data, but that it does not have access to that
data. It said the legislation will "drive BGI out of the U.S." and
limit competition.
Once it moves out of committee, the bill must pass in both the full
Senate and the House, and then needs be signed by the president.
(Reporting by Karen Freifeld; Editing by Stephen Coates)
[© 2024 Thomson Reuters. All rights
reserved.]
This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
|